These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12581969)

  • 1. [Clinical value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting recurrent nasopharyngeal carcinoma at the parapharyngeal space after radiotherapy].
    Wu DH; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):159-61. PubMed ID: 12581969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
    Yu DF; Zuo CT; Dai JZ; Dong MJ; Zhao J; Lin XT; Guan YH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1538-41. PubMed ID: 15566675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
    Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings.
    Tsai MH; Huang WS; Tsai JJ; Chen YK; Changlai SP; Kao CH
    Anticancer Res; 2003; 23(4):3513-6. PubMed ID: 12926100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
    Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
    Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M
    Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided needle biopsy through mandibular area for the diagnosis of nasopharyngeal carcinoma in the parapharyngeal space.
    Su Y; Zhao C; Li WJ; Deng XY; Zeng RF; Cui NJ; Lu TX
    Chin J Cancer; 2010 Aug; 29(8):768-73. PubMed ID: 20663325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
    Lai CH; Huang KG; See LC; Yen TC; Tsai CS; Chang TC; Chou HH; Ng KK; Hsueh S; Hong JH
    Cancer; 2004 Feb; 100(3):544-52. PubMed ID: 14745871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
    Yen RF; Hung RL; Pan MH; Wang YH; Huang KM; Lui LT; Kao CH
    Cancer; 2003 Jul; 98(2):283-7. PubMed ID: 12872346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
    Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
    J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
    Kao CH; ChangLai SP; Chieng PU; Yen RF; Yen TC
    J Clin Oncol; 1998 Nov; 16(11):3550-5. PubMed ID: 9817274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.
    Tsai MH; Shiau YC; Kao CH; Shen YY; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 May; 128(5):279-82. PubMed ID: 12029444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas.
    Nishioka T; Shiga T; Shirato H; Tsukamoto E; Tsuchiya K; Kato T; Ohmori K; Yamazaki A; Aoyama H; Hashimoto S; Chang TC; Miyasaka K
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1051-7. PubMed ID: 12095574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of 18FDG-PET in diagnosing and detecting residue or recurrence of nasopharyngeal carcinoma].
    Li WH; Huang XM; Zeng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jan; 42(1):65-6. PubMed ID: 17432361
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
    Tang LL; Ma J; Chen Y; Zong JF; Sun Y; Wang Y; Wu HB; Cui NJ
    Ai Zheng; 2007 Jul; 26(7):737-41. PubMed ID: 17626750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.